Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Merrill

Showing results (181-190 of 414) with videos related to

Pageof 42
Sort By:
Journal of the American Academy of Dermatology|July 20, 2020
Evaluating change in disease activity needed to reflect meaningful improvement in quality of life for clinical trials in cutaneous lupus erythematosusSrita Chakka, Rebecca L Krain, Sarah Ahmed, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 15, 1991
Staurosporine inhibits neutrophil phagocytosis but not iC3b binding mediated by CR3 (CD11b/CD18)R A Roubey, G D Ross, J T Merrill, et al.
Journal of Biomedical Materials Research|March 1, 1972
The Monsanto polyacrylonitrile hollow-fiber artificial kidneyI O Salyer, G L Ball, Beemsterboer, et al.
Clinical Immunology (Orlando, Fla.)|December 8, 2016
Prognostic significance of repeat biopsy in lupus nephritis: Histopathologic worsening and a short time between biopsies is associated with significantly increased risk for end stage renal disease and deathCristina Arriens, Sixia Chen, David R Karp, et al.
Journal of Autoimmunity|May 26, 2015
Renal involvement in lupus is characterized by unique DNA methylation changes in naïve CD4+ T cellsPatrick Coit, Paul Renauer, Matlock A Jeffries, et al.
Lupus Science & Medicine|September 26, 2015
DNA methylation patterns in naïve CD4+ T cells identify epigenetic susceptibility loci for malar rash and discoid rash in systemic lupus erythematosusPaul Renauer, Patrick Coit, Matlock A Jeffries, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 26, 2016
Epigenetic Reprogramming in Naive CD4+ T Cells Favoring T Cell Activation and Non-Th1 Effector T Cell Immune Response as an Early Event in Lupus FlaresPatrick Coit, Mikhail G Dozmorov, Joan T Merrill, et al.
Thrombosis and Haemostasis|September 30, 2003
Antibodies directed to protein S in patients with systemic lupus erythematosus: prevalence and clinical significanceMaria Laura Bertolaccini, Giovanni Sanna, Shvaita Ralhan, et al.
The Journal of Rheumatology|December 1, 2004
Defining response in systemic lupus erythematosus: a study by the Systemic Lupus International Collaborating Clinics groupSean J Wollaston, Vernon T Farewell, David A Isenberg, et al.
Frontiers in Immunology|February 13, 2016
Antiglutamate Receptor Antibodies and Cognitive Impairment in Primary Antiphospholipid Syndrome and Systemic Lupus ErythematosusMaria Gerosa, Barbara Poletti, Francesca Pregnolato, et al.
Pageof 42

Showing results (181-190 of 414) with videos related to

Sort By:
Pageof 42
Journal of the American Academy of Dermatology|July 20, 2020
Evaluating change in disease activity needed to reflect meaningful improvement in quality of life for clinical trials in cutaneous lupus erythematosusSrita Chakka, Rebecca L Krain, Sarah Ahmed, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 15, 1991
Staurosporine inhibits neutrophil phagocytosis but not iC3b binding mediated by CR3 (CD11b/CD18)R A Roubey, G D Ross, J T Merrill, et al.
Journal of Biomedical Materials Research|March 1, 1972
The Monsanto polyacrylonitrile hollow-fiber artificial kidneyI O Salyer, G L Ball, Beemsterboer, et al.
Clinical Immunology (Orlando, Fla.)|December 8, 2016
Prognostic significance of repeat biopsy in lupus nephritis: Histopathologic worsening and a short time between biopsies is associated with significantly increased risk for end stage renal disease and deathCristina Arriens, Sixia Chen, David R Karp, et al.
Journal of Autoimmunity|May 26, 2015
Renal involvement in lupus is characterized by unique DNA methylation changes in naïve CD4+ T cellsPatrick Coit, Paul Renauer, Matlock A Jeffries, et al.
Lupus Science & Medicine|September 26, 2015
DNA methylation patterns in naïve CD4+ T cells identify epigenetic susceptibility loci for malar rash and discoid rash in systemic lupus erythematosusPaul Renauer, Patrick Coit, Matlock A Jeffries, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 26, 2016
Epigenetic Reprogramming in Naive CD4+ T Cells Favoring T Cell Activation and Non-Th1 Effector T Cell Immune Response as an Early Event in Lupus FlaresPatrick Coit, Mikhail G Dozmorov, Joan T Merrill, et al.
Thrombosis and Haemostasis|September 30, 2003
Antibodies directed to protein S in patients with systemic lupus erythematosus: prevalence and clinical significanceMaria Laura Bertolaccini, Giovanni Sanna, Shvaita Ralhan, et al.
The Journal of Rheumatology|December 1, 2004
Defining response in systemic lupus erythematosus: a study by the Systemic Lupus International Collaborating Clinics groupSean J Wollaston, Vernon T Farewell, David A Isenberg, et al.
Frontiers in Immunology|February 13, 2016
Antiglutamate Receptor Antibodies and Cognitive Impairment in Primary Antiphospholipid Syndrome and Systemic Lupus ErythematosusMaria Gerosa, Barbara Poletti, Francesca Pregnolato, et al.
Pageof 42